Following BP Guidelines Will Save Lives and Money

Share this content:
Following BP Guidelines Will Save Lives and Money
Following BP Guidelines Will Save Lives and Money

(HealthDay News) -- If all Americans had their hypertension under control, 56,000 fewer cardiovascular events would occur each year. And 13,000 fewer people would die -- without increasing health costs, according to research published in the Jan. 29 issue of the New England Journal of Medicine.

Kirsten Bibbins-Domingo, M.D., Ph.D., professor of medicine at the University of California in San Francisco, and colleagues developed a computer simulation to project the effect of guideline adherence on adults aged 35 to 74. The authors specifically looked at treatment costs and lives saved.

Full implementation of the new hypertension guidelines would reduce deaths and treatment costs for men and women ages 45 to 74 with cardiovascular disease, the researchers found. It would also prevent those with moderate hypertension from developing cardiovascular disease, Bibbins-Domingo told HealthDay. The results of the study suggest it's not cost-effective to treat women aged 35 to 44 who don't have cardiovascular disease for moderate hypertension. The researchers did not look at the cost-effectiveness of treating hypertension in patients older than 74, which is the focus of another study.

"If we would get blood pressure under control, we would not only improve health, but we would also save money," Bibbins-Domingo said. "An investment in strategies to lower blood pressure will yield large health benefits as well as economic benefits." Such measures could include more medical appointments for people with elevated blood pressure, home blood pressure monitoring, and measures to improve medication compliance, Bibbins-Domingo suggested.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths